Gabor Franz, Schwarzbauer Andrea, Wirth Michael
Institute of Pharmaceutical Technology and Biopharmaceutics, The University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria.
Int J Pharm. 2002 Apr 26;237(1-2):227-39. doi: 10.1016/s0378-5173(02)00049-2.
To examine whether the dietary lectin wheat germ agglutinin (WGA) can facilitate binding and uptake of protein drugs due to its cytoadhesive and cytoinvasive properties, conjugates were prepared by covalent coupling of fluorescein-labeled bovine serum albumin (F-BSA) to WGA using divinylsulfone for crosslinking. Increasing the molar ratio of F-BSA/WGA resulted in 2.6-8.7 times higher Caco-2 binding as compared with glycyl-F-BSA. About 75% of F-BSA-WGA were bound specifically to Caco-2 cells according to inhibition studies in presence of the complementary carbohydrate. The Caco-2 association of F-BSA-WGA was temperature-dependent indicating active uptake of membrane bound conjugate, which was confirmed by confocal microscopy. The conjugate accumulated within lysosomal compartments followed by proteolytic degradation of F-BSA-WGA 1-4 h after conjugate loading as observed by equilibrating the intracellular pH with monensin. Finally low molecular weight degradation products of the proteinaceous prodrug appear in the extracellular medium. Contrary to Caco-2 single cells, a minor part of the conjugate is degraded by brush border proteases already 30 min after exposure to Caco-2 monolayers. But most of the conjugate is taken up into differentiated cells and processed as in single cells. Though the enzymic barrier remains to be surmounted, WGA-mediated drug delivery is a promising strategy for peroral delivery of even high molecular weight drugs to overcome the mucosal barrier.
为了研究膳食凝集素麦胚凝集素(WGA)因其细胞黏附性和细胞侵袭性是否能够促进蛋白质药物的结合与摄取,使用二乙烯砜进行交联,通过荧光素标记的牛血清白蛋白(F-BSA)与WGA共价偶联制备了缀合物。与甘氨酰-F-BSA相比,增加F-BSA/WGA的摩尔比导致Caco-2细胞的结合率提高了2.6至8.7倍。根据在存在互补碳水化合物的情况下进行的抑制研究,约75%的F-BSA-WGA特异性结合到Caco-2细胞上。F-BSA-WGA与Caco-2细胞的结合具有温度依赖性,表明膜结合缀合物的主动摄取,共聚焦显微镜证实了这一点。如通过用莫能菌素平衡细胞内pH所观察到的,缀合物在溶酶体区室中积累,随后在缀合物加载后1至4小时F-BSA-WGA发生蛋白水解降解。最后,蛋白质前药的低分子量降解产物出现在细胞外培养基中。与Caco-2单细胞相反,在暴露于Caco-2单层30分钟后,一小部分缀合物就已经被刷状缘蛋白酶降解。但大多数缀合物被分化细胞摄取并像在单细胞中一样进行处理。尽管酶屏障仍有待克服,但WGA介导的药物递送是一种有前景的策略,用于口服递送甚至高分子量药物以克服黏膜屏障。